(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.04%) $78.35
(0.63%) $2.22
(0.00%) $2 324.30
(-0.27%) $27.47
(0.01%) $988.50
(0.19%) $0.930
(0.47%) $10.88
(0.46%) $0.800
(0.11%) $91.44
Live Chart Being Loaded With Signals
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies...
Stats | |
---|---|
今日成交量 | 4.43M |
平均成交量 | 2.43M |
市值 | 2.59B |
EPS | HKD0 ( 2024-03-28 ) |
下一个收益日期 | ( HKD0 ) 2024-05-28 |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 31.75 |
ATR14 | HKD0.00500 (0.39%) |
音量 相关性
Frontage Holdings Corp 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Frontage Holdings Corp 相关性 - 货币/商品
Frontage Holdings Corp 财务报表
Annual | 2023 |
营收: | HKD259.86M |
毛利润: | HKD78.39M (30.17 %) |
EPS: | HKD0.00530 |
FY | 2023 |
营收: | HKD259.86M |
毛利润: | HKD78.39M (30.17 %) |
EPS: | HKD0.00530 |
FY | 2022 |
营收: | HKD250.36M |
毛利润: | HKD89.19M (35.63 %) |
EPS: | HKD0.0126 |
FY | 2021 |
营收: | HKD184.44M |
毛利润: | HKD66.70M (36.16 %) |
EPS: | HKD0.00900 |
Financial Reports:
No articles found.
Frontage Holdings Corp
Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies, as well as bioequivalence studies. It offers laboratory testing services, such as method development and validation, and sample analysis and central laboratory services; chemistry, manufacturing, and control services, including assistance in drug product development and analysis, and delivery and supply of clinical trial materials; and drug metabolism and pharmacokinetic services that include study designs, execution of studies, and interpretation of the data through structural optimization in early discovery, pharmacokinetic studies in rodents, non- GLP bioanalytical studies, etc. The company also provides safety and toxicology services comprising in-vitro and in-vivo studies; bioequivalence services, which consist of designing, coordinating, and reporting of bioequivalence studies; chemistry services comprising contract research and custom synthesis services; and clinical services, such as early stage clinical, BE/BA, biometric, and data management services. It operates in the United States, the People's Republic of China, Europe, India, Japan, South Korea, and Australia. The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation is a subsidiary of Hongkong Tigermed Co., Limited.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。